Envoy Medical Submits First PMA Module to FDA; 12-Month Clinical Improvement Reported

COCH Envoy Medical Inc

$0.65 +0.03%

View chart & analysis →

1. 1Envoy Medical (COCH) has submitted the first module of its modular PMA for the fully implantable Acclaim cochlear implant to the FDA.
2. 2In the first-stage cohort of 10 patients, the 12-month CNC word recognition score improved by 38.0 percentage points, from 15.2% pre-implant to 53.2%.
3. 3The remaining modules will be submitted sequentially, with the final module targeted for the second quarter of 2027, and primary efficacy will be evaluated using the 12-month data.

Source Newsfile Corp. +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →